# Senti Biosciences Holdings, Inc.: Form SCHEDULE 13D, filed Mar 13, 2025

- Company: [Senti Biosciences Holdings, Inc.](/companies/snti.md) (CIK 1854270)
- Form: SCHEDULE 13D
- Filed: 2025-03-13
- Accepted by EDGAR: Mar 13, 2025, 16:31 ET
- Period: not reported
- Accession: 0001079973-25-000383
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1854270/000107997325000383/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1854270/000107997325000383/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1854270/000107997325000383/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 13, 2025.
Source: SEC EDGAR, the filing index for accession 0001079973-25-000383. Last ingested by Listed: Nov 14, 2026, 22:37 ET. No prices; not investment advice.
